Related Experiment Videos

Proton MR spectroscopy reveals lactate in infantile neuroaxonal dystrophy (INAD)

I Mader1, I Krägeloh-Mann, U Seeger

  • 1Section of Experimental MR of the CNS, Department of Neuroradiology, Tübingen University School of Medicine, Germany. irina.mader@med.uni-tuebingen.de

Neuropediatrics
|June 21, 2001
PubMed

Insights

Proton MR spectroscopy detected lactate in the basal ganglia of infantile neuroaxonal dystrophy patients. This finding aids in diagnosing this rare neurological disorder.

Area of Science:

  • Neurology
  • Biochemistry
  • Medical Imaging

Background:

  • Infantile neuroaxonal dystrophy (INAD) is a rare, inherited neurodegenerative disorder.
  • Diagnosis typically relies on a combination of clinical, neuropathological, and neuroradiological data.
  • Proton MR spectroscopy (1H-MRS) offers a non-invasive method to assess brain metabolites.

Observation:

  • Two cases of INAD were investigated using MRI and 1H-MRS of the basal ganglia.
  • Increased signal intensity in the cerebellar cortex was noted on T2-weighted, proton density, and FLAIR images.
  • Long echo time (135 ms) 1H-MRS revealed lactate in the basal ganglia of both patients.

Findings:

  • The N-acetylaspartate/creatine ratio was reduced in both cases.
  • The choline/creatine ratio was consistently elevated.
  • Lactate was a significant finding in the basal ganglia spectra of INAD patients.

Implications:

  • The presence of basal ganglia lactate in 1H-MRS spectra may serve as a biomarker for INAD.
  • This spectroscopic finding can assist in narrowing the differential diagnosis of INAD.
  • It may support the decision for more invasive diagnostic procedures, such as biopsies.

Related Concept Videos